The correlation between DAMPs and clinical symptoms of cancer has been reported by several studies as either a positive or a negative correlation, for example, high HMGB1 levels proportionally associated with poor overall survival in patients with advanced hepatocarcinoma treatment [6]. The gene discussed is HMGB1; the disease is cancer.